When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Cyclacel Pharmaceuticals ( NASDAQ: CYCC ) has announced that it received a payment of £3.9M ($4.7M) as a R&D tax credit from HMRC, the tax agency of the United Kingdom government.
“We appreciate the UK government’s support as we develop our novel, oral medicines, fadraciclib and plogosertib, to address unmet medical needs of oncology patients, including patients with women’s cancers and lymphoma,” said Paul McBarron, Executive VP, Finance & COO.